Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
about
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer.Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.
P2860
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@ast
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@en
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@nl
type
label
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@ast
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@en
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@nl
prefLabel
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@ast
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@en
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@nl
P2093
P2860
P1433
P1476
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
@en
P2093
Corrie B Burmeister
Jason R Gee
Kyungmann Kim
Thomas C Havighurst
P2860
P304
P407
P577
2009-10-01T00:00:00Z